九洲药业：全资子公司获得高新技术企业认定

Core Viewpoint - Jiuzhou Pharmaceutical (603456.SH) announced that its wholly-owned subsidiary, Zhejiang Ruibo Pharmaceutical Co., Ltd., has been recognized as a high-tech enterprise, which will allow the company to benefit from tax incentives for the next three years [1] Group 1 - Zhejiang Ruibo Pharmaceutical Co., Ltd. received the high-tech enterprise certification with certificate number GR202533010708, issued on December 19, 2025, and valid for three years [1] - The company will enjoy a reduced corporate income tax rate of 15% from 2025 to 2027 due to its high-tech enterprise status [1]